Harsch Mutya
Insider CIK 1727809 · MNLO Chief Legal Officer and GC · FOMX General Counsel and SVP · STSA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-07-23 | 2026-07-24 | 22,516 | $0.90 | $20.3K | 95,918 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-06-30 | 2026-07-02 | 3,464 | $0.65 | $2.3K | 118,434 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-03-31 | 2026-04-02 | 4,007 | $0.60 | $2.4K | 121,898 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 3,579 | $0.58 | $2.1K | 125,905 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-09-30 | 2025-10-02 | 3,581 | $0.34 | $1.2K | 129,484 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-06-30 | 2025-07-02 | 3,581 | $1.65 | $5.9K | 133,065 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2025-06-02 | 2025-06-03 | 1,145 | $0.81 | $927 | 136,646 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-03-31 | 2025-04-02 | 8,828 | $1.58 | $13.9K | 135,501 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2025-01-21 | 2025-01-23 | 230,000 | — | $0 | 230,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-12-31 | 2025-01-02 | 4,697 | $3.35 | $15.7K | 144,329 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-09-30 | 2024-10-02 | 105 | $1.88 | $197 | 149,026 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 143 | $1.92 | $275 | 149,131 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-04-01 | 2024-04-03 | 161 | $3.08 | $496 | 149,274 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-01-02 | 2024-01-03 | 161 | $2.28 | $367 | 149,435 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2024-01-01 | 2024-01-03 | 62,500 | — | $0 | 149,596 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-12-13 | 2023-12-15 | 62,500 | — | $0 | 87,096 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-10-02 | 2023-10-04 | 1,154 | $3.83 | $4.4K | 24,596 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-06-30 | 2023-07-05 | 157 | $4.10 | $644 | 25,750 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 40,000 | — | $0 | 0 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-05-31 | 2023-06-02 | 3,664 | $3.46 | $12.7K | 25,907 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-03-31 | 2023-04-04 | 478 | $3.08 | $1.5K | 22,243 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | P Buy | 2023-03-20 | 2023-03-22 | 10,000 | $2.50 | $25.0K | 22,721 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-12-31 | 2023-01-04 | 1,813 | $0.15 | $272 | 229,144 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-09-30 | 2022-10-04 | 1,813 | $0.22 | $399 | 230,957 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-06-30 | 2022-07-05 | 1,813 | $0.39 | $707 | 232,770 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 3,630 | $0.65 | $2.4K | 234,583 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-03-17 | 2022-03-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-03-17 | 2022-03-18 | 75,000 | — | $0 | 238,213 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-12-31 | 2022-01-04 | 1,484 | $1.02 | $1.5K | 163,213 | SEC↗ |
| STSA Satsuma Pharmaceuticals, I | A Award deriv | 2021-10-11 | 2021-10-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-09-30 | 2021-10-01 | 1,484 | $1.39 | $2.1K | 164,697 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-09-02 | 2021-09-03 | 60,860 | — | $0 | 60,860 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-09-02 | 2021-09-03 | 60,859 | — | $0 | 166,181 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-06-30 | 2021-07-02 | 3,551 | $3.51 | $12.5K | 105,322 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-03-31 | 2021-04-02 | 1,765 | $6.84 | $12.1K | 108,873 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-02-22 | 2021-02-24 | 68,162 | — | $0 | 68,162 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-02-22 | 2021-02-24 | 29,213 | — | $0 | 110,638 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-12-31 | 2021-01-05 | 1,822 | $1.58 | $2.9K | 325,703 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2020-11-30 | 2020-12-02 | 10,460 | $1.45 | $15.2K | 327,525 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 1,822 | $1.66 | $3.0K | 317,065 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-06-30 | 2020-07-02 | 1,822 | $1.73 | $3.2K | 318,887 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-05-06 | 2020-05-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-05-06 | 2020-05-08 | 150,000 | — | $0 | 320,712 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-04-06 | 2020-04-07 | 4,474 | $1.40 | $6.3K | 170,712 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 92,302 | — | $0 | 175,186 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 26,381 | — | $0 | 82,884 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-03-31 | 2020-04-02 | 1,688 | $2.68 | $4.5K | 56,503 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 50,000 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 70,297 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 96,365 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 57,086 | — | $0 | 57,086 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 29,620 | — | $0 | 29,620 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 41,643 | — | $0 | 41,643 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 85,490 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 12,742 | — | $0 | 85,490 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 50,643 | — | $0 | 58,191 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 7,548 | — | $0 | 7,548 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-03-02 | 2020-03-03 | 1,761 | $2.68 | $4.7K | 98,232 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2020-02-24 | 2020-02-24 | 96,365 | — | $0 | 96,365 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-24 | 2020-02-24 | 41,299 | — | $0 | 96,471 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-12-31 | 2020-01-03 | 618 | $3.28 | $2.0K | 55,172 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-11-29 | 2019-12-03 | 4,284 | $2.16 | $9.3K | 55,790 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-09-30 | 2019-10-02 | 463 | $3.07 | $1.4K | 51,506 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-07-01 | 2019-07-03 | 639 | $2.35 | $1.5K | 51,969 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-04-01 | 2019-04-03 | 2,519 | $3.75 | $9.4K | 52,608 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2019-01-01 | 2019-01-03 | 70,297 | $3.77 | $265.0K | 70,297 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-01-01 | 2019-01-03 | 30,127 | — | $0 | 55,127 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-02-27 | 2018-02-28 | 50,000 | $6.35 | $317.5K | 50,000 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2018-02-27 | 2018-02-28 | 25,000 | — | $0 | 25,000 | SEC↗ |